Share on StockTwits

Acceleron Pharma (NASDAQ:XLRN) announced its earnings results on Thursday. The company reported ($0.30) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.44) by $0.14, ARN reports. The company had revenue of $3.31 million for the quarter, compared to the consensus estimate of $2.85 million.

Shares of Acceleron Pharma (NASDAQ:XLRN) opened at 31.75 on Thursday. Acceleron Pharma has a one year low of $16.78 and a one year high of $57.89. The stock has a 50-day moving average of $34.69 and a 200-day moving average of $36.02. The company’s market cap is $989.3 million.

In other Acceleron Pharma news, Director Jean George sold 215,644 shares of Acceleron Pharma stock on the open market in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $42.86, for a total transaction of $9,242,501.84. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.